EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Exploring Age and Sex Differences in the Use of Cannabis Vaping Products: Results From the Canadian Cannabis Survey 2020–2023

Fathima Fataar, Matthew J Dann, Samantha Goodman, Hanan Abramovici

Drug and Alcohol Review · 2026-05 · 45 (4)

DOI: 10.1111/dar.70155 ↗

At a glance

Journal article in Drug and Alcohol Review, published online on 2026-04-13. Written by Fathima Fataar and 3 co-authors. Institution: Office of Cannabis Science and Surveillance, Controlled Substances and Cannabis Branch, Health Canada, Ottawa, Canada. Major MEDLINE topics: Vaping, Cannabis, Marijuana Smoking. 41 references. The full text is freely available (open access, CC BY 4.0). Funded by: Health Canada.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Introduction

Use of cannabis vaping products has been increasing in Canada. This study examined the prevalence and patterns of use of cannabis vaping products, including higher‐risk use, by sex and age.

Methods

Data were from four cycles of the Canadian Cannabis Survey, an annual web‐based survey of people aged ≥ 16 years in Canada. Past 12‐month consumers of cannabis for non‐medical purposes were analysed ( n 2020 = 3405; n 2021 = 2802; n 2022 = 2801; n 2023 = 2972). Cannabis vaping measures included frequency of use and co‐use with nicotine or tobacco. Logistic regression models tested differences in outcomes, overall and by sex and age.

Results

Among past 12 month cannabis consumers, use of cannabis vaping products in the past 12 months increased from 22% (95% CI 20%–23%) in 2020 to 37% (95% CI 35%–39%) in 2023, with increases in all sex and age categories, most notably youth (16–19 years) whose use doubled from 33% (95% CI 27%–38%) to 66% (95% CI 60%–72%). Daily/almost daily use of cannabis vaping products also increased overall, from 2% (95% CI 1%–2%) in 2020 to 6% (95% CI 5%–7%) in 2023. There were few sex differences in patterns of use. The proportion of vaping product consumers classified as low risk increased from 13% (95% CI 10.3–16.6) in 2020 to 22% (95% CI 19.1–24.7) in 2023. The proportion classified as high risk also increased, while the proportion classified as moderate risk decreased. Discussion and Conclusions Following legalization (2020 to 2023), there was a continued increase in the use of cannabis vaping products, especially among youth. Continued monitoring as well as additional public education efforts, especially related to potency and risks of vaping, are warranted.

Subjects

MeSH terms (MEDLINE)

VapingCannabisMarijuana SmokingHumansCanadaAdolescentAge FactorsFemaleMaleAdultYoung AdultSex FactorsSurveys and QuestionnairesMiddle AgedPrevalence

Author keywords

age groupscanadacannabissexvaping

Authors and institutions

  • Office of Cannabis Science and Surveillance, Controlled Substances and Cannabis Branch, Health Canada, Ottawa, Canada.
  • School of Public Health Sciences, University of Waterloo, Waterloo, Canada.

Funding

  • Health Canada

Cite

APA

Fataar, F., Dann, M. J., Goodman, S., & Abramovici, H. (2026). Exploring Age and Sex Differences in the Use of Cannabis Vaping Products: Results From the Canadian Cannabis Survey 2020–2023. Drug and Alcohol Review, 45(4). https://doi.org/10.1111/dar.70155

Vancouver

Fataar F, Dann MJ, Goodman S, Abramovici H. Exploring Age and Sex Differences in the Use of Cannabis Vaping Products: Results From the Canadian Cannabis Survey 2020–2023. Drug and Alcohol Review. 2026;45(4). doi:10.1111/dar.70155

BibTeX
@article{Fataar2026,
  author = {Fataar, Fathima and Dann, Matthew J and Goodman, Samantha and Abramovici, Hanan},
  title = {Exploring Age and Sex Differences in the Use of Cannabis Vaping Products: Results From the Canadian Cannabis Survey 2020–2023},
  journal = {Drug and Alcohol Review},
  year = {2026},
  volume = {45},
  number = {4},
  doi = {10.1111/dar.70155}
}
Start for free →